DBLG1
LIVE

Serial Number

79256134

Owner

DIABELOOP

Attorney

Aaron Y. Silverstein

Filing Date

Dec 4, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DBLG1 Trademark

Serial Number: 79256134 • Registration: 6066262

DBLG1 is a trademark filed by DIABELOOP on December 4, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DIABELOOP (12 trademarks)

17 Rue Félix Esclangon

Entity Type: 99

Trademark Details

Filing Date

December 4, 2018

Registration Date

June 2, 2020

Published for Opposition

March 17, 2020

Goods & Services

Downloadable databases enabling computer storage and reading of data in the field of medical statistics; data processing equipment, namely, calculators; recorded computer software for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; downloadable computer programs for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; data downloadable on a computer or on a mobile telephone, namely, downloadable files containing medical information; computer terminals; mobile data terminals (MDT); Internet and intranet servers; computer and network servers; computer database servers; computer peripheral devices; intercommunication apparatus, namely, telephones and dedicated mobile handsets incorporating intercommunication systems; computer interface boards; electronic card readers being data processing equipment; downloadable electronic publications in the nature of books, electronic books, magazines, and newsletters, in the field of medicine and science; wearable activity sensors in the nature of wearable activity tracker; diagnostic apparatus for detection of hypoglycemia and hyperglycemia not for medical use; sensors, namely, pressure and temperature sensors; downloadable computer application software for treatment of diabetes; downloadable software applications for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; downloadable software applications for mobile devices for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; information display terminals in the nature of liquid crystal displays (LCDs); electronic devices for digital display, namely, electronic display interfaces

Medical services; medical analysis services to diagnose and treat people; medical information; providing medical information provided via the Internet; providing information via the Internet in the field of diabetes; providing medical information; diabetes screening service; medical services in the field of diabetes; medical screening; medical testing for diagnostic or treatment purposes, medical care, physical examinations services, and medical treatment; advisory services concerning medical services; medical assistance; medical evaluation services, namely, medical testing for diagnostic or treatment purposes; medical consultation; medical technical assistance services relating to health, namely, medical assistance services provided via the internet for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; health services, namely, administration of insulin; hospital services; surgical treatments for diabetes or its effects; telemedicine services; advisory services relating to health; pharmaceutical advice; medical equipment rental; telemedicine services in the nature of telediagnosis services rendered via the Internet; telemedicine services in the nature of telediagnosis services including the remote transmission of medical data

Diagnostic test apparatus for medical purposes, namely, for the prevention and treatment of diabetes; diagnostic apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, thermometers; blood testing apparatus; medical apparatus and instruments, namely, infusion and injection devices for administering drugs and other medicaments; Surgical instruments and apparatus; pumps for medical use, namely, subcutaneous diffusion pumps for insulin and other hormones used in diabetes treatment; apparatus for measuring blood sugar for medical purposes; medical diagnostic apparatus for testing blood glucose levels; insulin syringes for medical purposes, sold empty; sensors used for medical diagnosis, namely, glucose sensors; sensors for medical use for monitoring patients' vital signs; medical test kits for home monitoring of diabetes

Evaluations and assessments in the fields of science and technology provided by engineers, namely, testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, and physical activity levels, and providing related reports and alerts; scientific research; technical research in the field of medicine; design and development of computers and software; research and development of new products for others; technical project study in the nature of scientific research in the field of medicine; development design, installation, maintenance, updating and rental of software; computer programming; computer system analysis; computer system design; consultancy relating to computers, namely, computer software consultancy; digitization of documents; software as a service (SaaS) services featuring software for use in database management in the medical field; information technology (IT) consultancy; hosting of servers; development and testing of computer programs, namely, computing methods and algorithms therein; development and testing of computer software; data hosting in the nature of server hosting; computer data security services, namely, restricting unauthorized network access to hard drives and computer servers; design and development of data processing programs; medical research services; providing online, non-downloadable computer programs for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 2, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 3, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 25, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 25, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 2, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Mar 13, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 26, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 26, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 12, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 12, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 12, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 12, 2020 CNEA
ASSIGNED TO EXAMINER
Feb 6, 2020 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 15, 2019 CRFA
ASSIGNED TO LIE
Nov 15, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 1, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 11, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 10, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 19, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 16, 2019 MAFR
ASSIGNED TO EXAMINER
Apr 12, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2019 REPR